ALS has increasing incidence worldwide even though with low prevalence. There is only one FDA-approved drug 'Riluzole' but with marginal effect and no preventive role. Nowadays, clinical researches are ongoing and numerous drugs are under development. Most of the drugs target mechanism to prevent neuronal cell death.egységes, osztatlanáltalános orvosango
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by de...
Effective treatments for amyotrophic lateral sclerosis (ALS) have remained elusive. Only riluzole, a...
Several mechanisms have been proposed to account for the progressive motor neurone death evident in ...
Amyotrophic lateral sclerosis (ALS) is a fatal chronic neurodegenerative disease whose hallmark is p...
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder involving lo...
International audienceAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease chara...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease resulting in increasi...
Introduction: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease...
Purpose Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. It is...
Owing to uncertainty on the pathogenic mechanisms underlying motor neuron degeneration in amyotrophi...
Owing to uncertainty on the pathogenic mechanisms underlying motor neuron degeneration in amyotrophi...
© 2017 Elsevier Inc. All rights reserved. Selective death of upper and lower motor neurons in the mo...
International audienceIntroduction: To date, riluzole and edaravone are the only two drugs that have...
International audienceAmyotrophic lateral sclerosis is a rare neurodegenerative disease. It is chara...
The preliminary analysis of a clinical trial of the drug riluzole, announced yesterday, shows it to ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by de...
Effective treatments for amyotrophic lateral sclerosis (ALS) have remained elusive. Only riluzole, a...
Several mechanisms have been proposed to account for the progressive motor neurone death evident in ...
Amyotrophic lateral sclerosis (ALS) is a fatal chronic neurodegenerative disease whose hallmark is p...
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disorder involving lo...
International audienceAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease chara...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease resulting in increasi...
Introduction: Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease...
Purpose Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease in adults. It is...
Owing to uncertainty on the pathogenic mechanisms underlying motor neuron degeneration in amyotrophi...
Owing to uncertainty on the pathogenic mechanisms underlying motor neuron degeneration in amyotrophi...
© 2017 Elsevier Inc. All rights reserved. Selective death of upper and lower motor neurons in the mo...
International audienceIntroduction: To date, riluzole and edaravone are the only two drugs that have...
International audienceAmyotrophic lateral sclerosis is a rare neurodegenerative disease. It is chara...
The preliminary analysis of a clinical trial of the drug riluzole, announced yesterday, shows it to ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by de...
Effective treatments for amyotrophic lateral sclerosis (ALS) have remained elusive. Only riluzole, a...
Several mechanisms have been proposed to account for the progressive motor neurone death evident in ...